CSL
Revenue FY growth 3%
NPAT FY down 6%
RMD
Revenue FY down 12%
NPAT FY flat, 21% of revenue
If you regard those results as doing fine, why do you put PME in the same basket..?
PME
Revenue FY growth 37%
NPAT FY growth 44%, 47% of revenue
Ann: PME Full year results, page-17
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$138.18 |
Change
0.520(0.38%) |
Mkt cap ! $14.42B | |||
| Open | High | Low | Value | Volume |
| $136.40 | $138.35 | $134.44 | $27.04M | 197.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 813 | $138.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $138.38 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| PME (ASX) Chart |